[Federal Register Volume 68, Number 106 (Tuesday, June 3, 2003)]
[Notices]
[Pages 33149-33150]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-13786]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-03-71]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 498-1210. CDC is requesting an emergency 
clearance for this data collection with a two week public comment 
period. CDC is requesting OMB approval of this package 7 days after the 
end of the public comment period.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Send comments to Anne O'Connor, CDC 
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 14 days 
of this notice.
    Proposed Project: Project DIRECT: Phase 2, Evaluation of Impact of 
Multilevel Community Interventions--New--National Center for Chronic 
Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease 
Control and Prevention (CDC). Project DIRECT (Diabetes Intervention 
Reaching and Educating Communities Together) is the first comprehensive

[[Page 33150]]

community based project in the United States to address the growing 
burden of diabetes in African Americans. The goal of the project is to 
use existing knowledge of diabetes risk factors and complications to 
implement community level interventions to reduce the prevalence and 
severity of diabetes in communities with large African American 
populations. A community in Raleigh, North Carolina was selected as the 
demonstration site for the project. An area in Greensboro, NC, was 
identified as a suitable comparison community. The Division of Diabetes 
Translation (DDT) at the Centers for Disease Control and Prevention 
(CDC) is collaborating with the state of North Carolina to implement 
and evaluate public health strategies for reducing the burden of 
diabetes in this predominately African American community.
    Project DIRECT has three distinct intervention components--Health 
Promotion, Outreach, and Diabetes Care. The goals of all three 
interventions are to reduce or prevent diabetes and its complications, 
but each has a different but complimentary approach.
    Project DIRECT implemented a baseline population-based survey in 
1996-1997. Interventions have been employed since then and continue to 
the present. A follow-up study is now required to evaluate the impact 
of this multilevel approach to diabetes prevention and control. Data 
from this project will be critical to the Division of Diabetes 
Translation's on-going efforts to reduce the burden of diabetes, and to 
determine whether a similar program could be implemented successfully 
in other communities. A pre-post design was selected for the evaluation 
to determine if any changes observed for these outcomes might be 
attributed to the interventions used in Project DIRECT by comparing 
changes in the intervention and comparison communities. The baseline 
study for the pre-post evaluation was conducted during 1996-1997. 
Households in Raleigh and Greensboro communities would be selected at 
random using mailing lists. An interviewer will verify the address and 
do an initial screening for eligible participants in the household. 
Eligible participants will be asked to participate in the study and 
will have to complete a consent form. All participants will be asked to 
complete an interview on their health status and lifestyle and measured 
for height and weight. Participants who self-report a history of 
diabetes will be asked additional questions (diabetes module) about 
their management of diabetes and its complications and other related 
health conditions.
    All participants who self-report a history of diabetes and a sub-
sample of those without diabetes would be invited to participate in a 
household examination that will include blood pressure and waist 
circumference measurement and a blood draw for laboratory analysis 
including blood glucose and lipids concentrations. For quality control 
purposes, a small sample of participants will be asked to do a short 
telephone interview to verify information collected during the general 
interview.
    The only cost to respondents is their time to participate in the 
study.

----------------------------------------------------------------------------------------------------------------
                                                                                  Average burden
                      Form                           Number of     Responses per   per response    Total burden
                                                    respondents     respondent        (hours)         (hours)
----------------------------------------------------------------------------------------------------------------
Screening Questionnaire.........................           4,600               1            5/60             383
General Population Questionnaire................           2,603               1           30/60           1,302
Diabetes Module.................................             565               1           30/60             283
Verification Questionnaire......................           1,535               1           30/60             768
                                                 -----------------
    Total.......................................           4,600  ..............  ..............           2,736
----------------------------------------------------------------------------------------------------------------


    Dated: May 28, 2003.
Thomas A. Bartenfeld,
Acting Director, Office of Program Planning and Evaluation, Centers for 
Disease Control Prevention.
[FR Doc. 03-13786 Filed 6-2-03; 8:45 am]
BILLING CODE 4163-18-P